CS Paper Radar

BRIDGE: Learning Brain-Gut Metabolic Evidence for Alzheimer's Disease Diagnosis

Pengli Zhu, Ruxi Chang, Tianliang Yao, Yu Jiang, Shengyuan Liu, Yiyang Lin, Xiaoyi Duan, Shuang Wu, Yixuan Yuan, the Alzheimer's Disease Neuroimaging Initiative

cs.CV ·submitted 2026-10-29 07:18 UTC · v1
code/data

Abstract

Alzheimer's disease (AD) diagnosis may benefit from gut metabolic information associated with brain-gut interactions, yet existing models largely analyze cerebral glucose metabolism alone. Although whole-body fluorodeoxyglucose positron emission tomography (FDG-PET) can provide paired brain-gut observations, routine brain examinations rarely include gut imaging, limiting direct use of this information for diagnosis. In this paper, we present BRIDGE (Brain and Gut Representation Integration via Distribution-Guided Enhancement), a two-stage framework for transferring brain-gut metabolic knowledge to brain-only diagnosis. Specifically, BRIDGE integrates a conditional brain-to-gut latent transport module and a disease-evidence-guided cerebral pathway to capture subject-specific cross-organ correspondence and disease-relevant cerebral representations. For the cerebral pathway, a large language model (LLM) helps organize literature-derived descriptors into human-approved semantic anchors that guide feature learning. Additionally, we introduce a counterfactual-guided residual fusion mechanism, which uses matched and non-matched virtual-gut evidence to supervise a confidence gate and dynamically regulate the contribution of transported cross-organ information. At inference, BRIDGE exploits complementary gut-related context using brain PET alone, without measured gut PET. Extensive experiments across public and private cohorts demonstrate that BRIDGE outperforms brain-only and cross-organ baselines, achieving AUC gains of 6.0% and 5.2% over its brain-only counterpart for CN/MCI and CN/AD diagnosis, respectively. Notably, its ability to transfer complementary brain-gut metabolic context while preserving brain PET as the sole inference input highlights its potential for clinically practical diagnosis. Our code is available at https://github.com/CUHK-AIM-Group/BRIDGE.

Comment
10 pages, 6 figures

Closest papers

Nearest neighbours by meaning across the whole index.

AG-JEPA: Anatomically Guided Joint Embedding Predictive Architecture for Neurodegenerative Representation Learning

cs.CV cs.AI ·2026-11-13 ·Azad Singh, Ayantika Das, Amog Rao, Aiman Farooq, Anirban Porya +5 more
similarity 0.62
Abstract

Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent. However, during the transition from cognitively normal (CN) to mild cognitive impairment (MCI), the disease-related signals are often subtle and confined to only a few brain regions. Existing Joint Embedding Predictive Architecture (JEPA) models learn general structural representations but do not explicitly capture the anatomical regions affected in AD. We propose Anatomically Guided JEPA (AG-JEPA), which introduces anatomical tokens that interact with patch tokens during pretraining to learn region-specific representations from brain regions relevant to neurodegeneration. Building on this representation space, we further propose Prog-AG-JEPA, which models disease progression trajectory as a conditioned latent displacement within this space. We evaluate AG-JEPA across five downstream tasks spanning Alzheimer's disease diagnosis and progression prediction. AG-JEPA improves diagnosis and MCI prognosis, achieving an 8.4 percentage point AUROC gain over the strongest baseline on CN/MCI classification and a 7.1 percentage point gain on out-of-distribution CN/AD classification on the MR-RATE dataset, highlighting its effectiveness across both early-stage detection and cross-cohort generalization. For disease progression modeling, Prog-AG-JEPA consistently outperforms all baselines on future diagnosis and brain volume change prediction, demonstrating the value of anatomically grounded neurodegeneration representations for diagnosis and prognosis.

0.09

A Multimodal Explainable Deep Learning Framework for Alzheimer's Disease Diagnosis using 3D Magnetic Resonance Imaging and Clinical Data

cs.CV stat.ML ·2026-09-11 ·Yusuf Brima, Marcellin Atemkeng, Lakshmana Rao Namamula, Antoine Vacavant
similarity 0.59
Abstract

Dementia is a major and growing global health burden, with Alzheimer's disease (AD) accounting for most cases. Timely and accurate diagnosis is central to managing this burden and increasingly depends on integrating complementary clinical and imaging information. Multimodal deep learning can combine these modalities for AD diagnosis, but how its explanations behave across modalities, fusion strategies, and cohorts remains unclear. We developed an explainable multimodal framework pairing a 3D CNN encoder for T1-weighted MRI with a feedforward network for harmonized clinical and demographic data, comparing varied model setups on three-way and pairwise diagnostic tasks using 6,479 internal records from the ADNI and 1,703 independent records from the OASIS-3. On ADNI, the tabular-only model achieved the highest three-class AUC-ROC of 0.879 and best discriminated cognitively normal (CN) versus mild cognitive impairment (MCI; 0.903), while cross-attention performed best for MCI versus AD (0.861); CN versus AD was highly discriminative overall. On OASIS-3, the vision-only model performed best (three-class AUC-ROC 0.910); CN versus MCI remained difficult, and no fusion strategy consistently outperformed single modalities across tasks and cohorts. SHAP and Integrated Gradients identified the MMSE as the dominant tabular feature in both cohorts, with global feature rankings agreeing strongly in ADNI ($ρ=0.94$) and OASIS-3 ($ρ=0.96$); CAM-based explanations, however, changed with model configuration and cohort. These findings show that multimodal performance and explanations are task, modality, fusion, and cohort-dependent: a dominant cognitive signal persisted across cohorts, but feature contributions and CAM explanations did not, underscoring the need to evaluate explainability under cohort shift rather than as a stable, intrinsic property.

0.10

dMRI-F: A Foundation Model for Generalizable Diffusion MRI Analysis from Sparse Acquisitions

cs.CV ·2026-10-13 ·Xi Zhu, Yijie Li, Xiaofan Wang, Wei Zhang, Huafu Chen +2 more
similarity 0.59
Abstract

Diffusion MRI (dMRI) probes water diffusion within the brain, providing unique information about tissue microstructure and white matter connectivity. High-quality dMRI enables advanced and accurate analyses but demands dense acquisitions, resulting in long scan times and hardware constraints that are often infeasible. Further, dMRI requires dedicated computational methods to support diverse analysis tasks (e.g., parcellation, registration, and synthesis) for both neuroscientific and clinical applications. Here, we present dMRI-F, a foundation model that unifies dMRI data enhancement and downstream tasks across diverse acquisitions and populations, while requiring only minimal acquisition input. dMRI-F is pre-trained with a q-space masked reconstruction task: predicting densely sampled multi-shell data from only six volumes. It learns generalizable latent feature representations of dMRI data, which serve as a core foundation for adapting to diverse downstream tasks, including brain parcellation, brain registration, and cross-modal synthesis. Across nine independently acquired datasets, we demonstrate that dMRI-F outperforms state-of-the-art methods with robust generalization across acquisitions, populations, and tasks. Our results demonstrate dMRI-F's versatility as a general-purpose framework that enables diverse dMRI applications from low-cost, sparse acquisitions.

0.15

Anatomical Grounding and Leakage-Aware Multimodal Contrastive Learning for Alzheimer's Disease Classification from Structural MRI

cs.CV cs.AI ·2026-09-14 ·Paul-Gabriel Nicolae, Irina Georgiana Mocanu
theory similarity 0.59
Abstract · 13 pages, 4 figures

Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irrelevant regions, and multimodal models that add clinical tables frequently rely on variables that were used to assign the diagnostic label in the first place. We study both issues with a deliberately lightweight slice-based encoder (ResNet18 with a one-layer Transformer over slices) on 1,075 baseline T1-weighted scans from ADNI-1. First, we use FastSurfer segmentations as an anatomical reference: YOLOv8 models trained on segmentation-derived labels localize Alzheimer-relevant structures with mAP_50 above 0.96, and a Grad-CAM comparison shows that the image-only classifier frequently attends to the skull, orbits and background. Second, we adapt a CLIP-style image - tabular contrastive framework and organize ADNIMERGE variables along a label-leakage spectrum. Fusion with cognitive scores yields 87.3% three-way accuracy, which we treat as a leakage-driven upper bound rather than an imaging result; fusion with regional volumes yields 73.0%. We observe that the choice of contrastive target changes what the image encoder learns: on MCI vs. CN, the image-only head reaches 52.4% when the encoder is aligned to cognitive scores and 73.8\% when aligned to volumes, although no tabular input is used at inference. Third, restricting the input to a per-subject crop of the medial temporal lobe raises image-only three-way accuracy from 58.7% to 65.1%. All results come from single runs on a small balanced test set, and we report confidence intervals and the protocol differences that prevent direct comparison with published numbers.

0.16

CoPoE: Multimodal Fusion via Decomposable Disease-Coordinate Product-of-Experts for Missing-Modality Alzheimer's Diagnosis

cs.LG cs.CV ·2026-10-08 ·Chihun An, Ikbeom Jang
publishedbenchmarkcode/data similarity 0.59
Abstract · Accepted at IEEE BIBM 2026

Multimodal Alzheimer's disease (AD) diagnosis benefits from integrating heterogeneous clinical, imaging, genomic, and biomarker evidence, but clinical cohorts frequently suffer from irregular modality missingness. Existing fusion methods often synthesize absent inputs, risking the introduction of artificial surrogates, or pool available signals into uninterpretable latent spaces. We present CoPoE (Disease-Coordinate Product-of-Experts), a disease-coordinate framework that maps multimodal evidence into a structured latent space partitioned into four distinct biological and clinical axes: genetic Risk, molecular Pathology, Neurodegeneration, and clinical Stage (R/P/N/S). Each observed modality parameterizes a diagonal Gaussian expert over the full RPNS vector, and a masked Product-of-Experts architecture fuses only the available modalities. Consequently, absent modalities add no factor to the fusion path, allowing the network to preserve a robust, decomposable posterior for any non-empty modality subset without synthetic imputation in the RPNS path. Through extensive missing-modality experiments on the ADNI dataset, CoPoE achieves the best all-modality performance and the highest mean AUROC across all 15 observed-subset evaluations among standardized missing-modality fusion baselines under a shared non-PET ADNI embedding benchmark, while substantially improving raw-probability ECE, Brier score, and NLL. Furthermore, PET-supervised probing shows evidence enrichment within the pathology (P) block under full modalities, with tau-related signal retained even when direct fluid biospecimen inputs are withheld. Our code is available at https://github.com/labhai/CoPoE.

0.44

A generative foundation model for computational brain imaging

cs.AI ·2026-10-30 ·Yuting He, Xu Wen, Hongxing Lan, Chengliang Liu, Yuxing Liu +8 more
similarity 0.58
Abstract

Computational brain imaging is constrained by a mismatch between increasingly diverse tasks and scarce, heterogeneous clinical data. Although existing brain foundation models transfer pretrained representations, their knowledge remains entangled within model-specific features and fixed architectures. This paper proposes BrainGFM, a generative foundation model that extends knowledge transfer beyond representation reuse through a reusable and reconfigurable brain-imaging prior. By pretraining on a corpus of about 1.3 million MRI and CT slices, BrainGFM supported task-aligned data synthesis for low-data predictive learning and task-adapted post-training for image reconstruction. Across 48 downstream tasks, BrainGFM improved segmentation and classification under limited supervision and achieved high-fidelity image enhancement across heterogeneous imaging conditions. Multicenter clinical validation involving 4,796 stroke patients across two internal and four external centers demonstrated its applicability to three clinically relevant tasks around stroke cohorts. Blinded reader assessments showed that BrainGFM-generated FLAIR images approached acquired FLAIR in overall diagnostic quality. In a human-AI collaboration study, BrainGFM assistance yielded a 14% relative improvement in mean radiologist stroke-subtyping accuracy. These findings support generative priors as a reusable foundation for heterogeneous computational brain-imaging applications.

0.17

A Generalizable Feature Extractor for Alzheimer's-Related Brain MRI Tasks

cs.CV q-bio.QM ·2026-09-04 ·Reza Rajabli, D. Louis Collins
similarity 0.58
Abstract · 26 pages (excluding the references section), 7 figures (excluding sub-figures)

When there is not enough labeled data to properly train deep learning models, transfer learning can help. We still do not fully understand how effective it is in neuroimaging, especially for Alzheimer's disease research. It is also not clear if these transferred models can work on new datasets without being retrained for each specific task. We evaluate whether a compact, supervised pretrained model can serve as a reusable foundation model for downstream neuroimaging tasks. We freeze the 7.18 million weights of a 3D CNN previously trained for brain-age prediction, and adapt it to each task using Low-Rank Adaptation (LoRA), requiring only ~1% additional trainable parameters. We evaluate generalizability in six experiments. Adapting the model to classify cognitively normal versus Dementia on ADNI gave an AUC of 0.964 on held-out folds (Experiment #1). Applying that adapted model unchanged to OASIS-3, with no retraining, gave an AUC of 0.871 (Experiment #2). Reusing its output logit together with age and a cognitive score distinguished stable from progressing MCI with an AUC of 0.828 (Experiment #3). Adapting the same backbone to predict amyloid positivity from structural MRI gave an AUC of 0.804 (Experiment #4). Finally, the same approach estimated ICV-normalized hippocampal and white matter hypointensity volumes directly from the T1w image, with R^2 of 0.80 and 0.91 respectively, tasks normally addressed with much larger U-Net networks (Experiments #5 and #6). A compact model supervised on brain age can therefore serve as a reusable backbone, adapting to each task with ~1% additional parameters and transferring to an unseen cohort without any training. Our findings suggest that a carefully trained brain age model can serve as an effective foundation model for Alzheimer's related tasks, even under strict data constraints.

0.18

Emergence of Transfer Learning towards Specific Identification of Alzheimer's Disease A Prospective Approach

cs.CV cs.DL ·2026-08-13 ·Soumik Podder, Chandramouli Haldar
published similarity 0.58
Abstract

Worldwide, millions of senior citizens are suffering from Alzheimer disease abbreviated as AD, a well- versed form of dementia. AD is featured by amnesia, intellectual disability, and difficulty with consciousness. DL and ML models are undoubtedly explored to identify AD related patterns on large dimensional neuroimaging data but they need global optimization and are suffering from overfitting issue that might yield dissatisfactory result in testing data set. DL overcomes the issue by convolution of input image with kernel but any sudden change in the MRI image or human manipulation, limited pre- processing of the images can mislead CNN in achieving highly accurate detection. Transfer Learning (TL) has proved itself in AD diagnosis by utilizing pre-trained models on large data sets to guide novice model in a new neuroimaging dataset. This review provides an inclusive glimpse of TL implication in classification, identification including the conversion of AD. Keeping in view, we have assessed the strengths and limitations of TL in improvising diagnostic accuracy even with limited data. The uniqueness of the present review is the incorporation of explainable AI in TL based AD diagnosis system. Finally, it can be claimed that the review will guide the new re-searchers in the area of TL induced neurodegenerative disease detection.

0.58